Table 1 Baseline Patient Demographics and Clinical Characteristics of Patients With and Without Allodynia
With Allodynia (n = 289) | Without Allodynia (n = 426) | |
|---|---|---|
Mean (SD) age, y | 42.3 (11.3) | 43.5 (11.2) |
Min, max | 18,72 | 18,73 |
Female, n (%) | 251 (86.9) | 355 (83.3) |
Race, n (%) | ||
Caucasian | 240 (83.0) | 341 (80.0) |
Black | 16 (5.5) | 25 (5.9) |
Asian | 31 (10.7) | 58 (13.6) |
Native Hawaiian or other Pacific Islander | 1 (0.3) | 2 (0.5) |
American Indian or Alaska Native | 1 (0.3) | 0 (0.0) |
Mean (SD) BMI, kg/m2 | 27.6 (6.5) | 27.3 (6.4) |
Mean (SD) age of migraine onset, y | 32.2 (13.1) | 32.7 (14.1) |
Mean (SD) time since onset of migraine, y | 10.2 (10.5) | 10.8 (11.3) |
Family history of migraine, n (%) | 179 (61.7) | 270 (63.4) |
Mean (SD) headache days at baseline | 21.7 (4.8) | 21.9 (4.9) |
Mean (SD) moderate to severe headache days at baseline | 17.9 (5.6) | 17.8 (5.7) |
Medication use at baseline, n (%)* | ||
Previously taken acute medications | 288 (99.3) | 419 (98.4) |
Previously taken preventive medications | 244 (84.1) | 335 (78.6) |